Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Amneal Pharmaceuticals Inc AMRX

Healthcare Drug Manufacturers - Specialty & Generic
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate... see more

Current News (NDAQ:AMRX)

Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®

GlobeNewswire December 22, 2025

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

GlobeNewswire December 9, 2025

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson's Disease

GlobeNewswire December 5, 2025

Amneal to Participate in Upcoming Investor Conferences

GlobeNewswire December 2, 2025

Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

GlobeNewswire December 2, 2025

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%

GlobeNewswire December 1, 2025

Amneal Receives U.S. FDA Approval for Iohexol Injection

GlobeNewswire November 13, 2025

Amneal Reports Third Quarter 2025 Financial Results

GlobeNewswire October 30, 2025

Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol

GlobeNewswire October 29, 2025
View More News ››

Opinion & Analysis (NDAQ:AMRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AMRX)

Yet More Insider Sales

After a year of no insider purchases yet more sales.  Can't they talk someone into buying a few shares?
GoldWatch - March 8, 2025

Insider Activity 2

These guys are killing me.  Another three insider sales.  
GoldWatch - March 5, 2025

Insider Activity

Starting to become concerned about the year of insider selling with no purchasing.  Not a good look.
GoldWatch - March 5, 2025

Share value +(earning/profit)=

2$ real share value 
Nibinator - January 7, 2024

RE:Question

Depends where you heard it..... if you heard it on CNN I wouldn't trust it...... CNN has been full of FAKE NEWS lately
JettJava - September 2, 2020

Question

I am reading a lot about AMRX and it's fight against Covid-19 for frontline workers. Does anyone know if a 3000 medical personnel...
Ritchipa - April 8, 2020
View more Bullboard ››

FPX Nickel Corp.

FPX Nickel Corp.

FPX Nickel Corp., a junior nickel mining company, engages in the acquisition, exploration, and development of mineral ...
View More »

Podcasts